CGLClass II
Electrode, Ion Based, Enzymatic, Creatinine
21 CFR 862.1225 / Clinical Chemistry
CGL is the FDA product code for Electrode, Ion Based, Enzymatic, Creatinine, a class II device type, regulated under 21 CFR 862.1225. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and 9 recalls.
Classification record
- Product code
- CGL
- Device name
- Electrode, Ion Based, Enzymatic, Creatinine
- Regulation
- 21 CFR 862.1225
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 8
- Ingested recalls
- 9
Clearances, product code CGL
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1991 | 1 |
| 1997 | 1 |
| 1999 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2026 | 1 |
Applicants with the most clearances
Product code CGL| Applicant | Clearances |
|---|---|
| Nova Biomedical Corporation | 3 |
| Abbott Medical | 1 |
| Epocal Inc | 1 |
| I-Stat Corp. | 1 |
| Radiometer Medical ApS | 1 |
| Swedish Trade Council USA | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
